Syndax Pharmaceuticals (SNDX)
(Delayed Data from NSDQ)
$18.27 USD
-0.36 (-1.93%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $18.26 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -1.13 |
EPS Last Quarter | -0.80 |
Last EPS Surprise | 12.09% |
ABR | 1.14 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.66 |
Next Year | -3.35 |
EPS (TTM) | -3.38 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.57M | 47.49M | 53.95M | 102.29M |
# of Estimates | 3 | 4 | 4 | 5 |
High Estimate | 12.50M | 106.50M | 110.10M | 140.80M |
Low Estimate | 0.20M | 1.18M | 4.68M | 73.26M |
Year ago Sales | 0.00M | 0.00M | NA | 53.95M |
Year over Year Growth Est. | NA | NA | NA | 89.63% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.13 | -0.76 | -3.66 | -3.35 |
# of Estimates | 7 | 5 | 7 | 7 |
Most Recent Consensus | -1.05 | -1.24 | -3.94 | -3.68 |
High Estimate | -1.05 | -0.02 | -2.79 | -2.49 |
Low Estimate | -1.26 | -1.24 | -4.15 | -3.68 |
Year ago EPS | -0.73 | -1.00 | -2.98 | -3.66 |
Year over Year Growth Est. | -54.79% | 24.00% | -22.82% | 8.39% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 4 | 4 | 5 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.13 | -0.76 | -3.66 | -3.35 |
7 Days Ago | -1.13 | -0.76 | -3.66 | -3.35 |
30 Days Ago | -1.13 | -0.76 | -3.66 | -3.35 |
60 Days Ago | -1.04 | -0.72 | -3.49 | -2.89 |
90 Days Ago | -1.05 | -0.83 | -3.56 | -2.95 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.13 | -0.76 | -3.66 | -3.35 |
Zacks Consensus Estimate | -1.13 | -0.76 | -3.66 | -3.35 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.80 | -0.85 | -1.00 | -0.73 | NA |
Estimate | -0.91 | -0.96 | -0.99 | -0.80 | NA |
Difference | 0.11 | 0.11 | -0.01 | 0.07 | 0.07 |
Surprise | 12.09% | 11.46% | -1.01% | 8.75% | 7.82% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more